उत्पाद विवरण
Krabeva 400 mg injection is a targeted anti-cancer therapy designed to combat various malignancies, including colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This innovative treatment contains Bevacizumab, a monoclonal antibody that effectively inhibits vascular endothelial growth factor (VEGF), a protein that plays a crucial role in tumor growth and blood vessel formation. By blocking VEGF, Krabeva helps to restrict the blood supply to tumors, thereby slowing their progression and enhancing the efficacy of other cancer treatments. It is essential to discuss potential side effects with your healthcare provider, as Krabeva may lead to serious conditions like high blood pressure or bleeding complications. As with any chemotherapy regimen, monitoring during treatment is vital to ensure patient safety and treatment effectiveness. Krabeva 400 mg is typically administered in conjunction with other anticancer medications, tailoring the therapy to individual patient needs. For those battling cancer, Krabeva represents a vital option in the fight against this challenging disease, offering hope for improved outcomes. Always consult your oncologist to determine if Krabeva is the right choice for your treatment plan.
Precise Dosage and Reliable AdministrationKrabeva 400 mg Injection is presented in a single-dose vial, guaranteeing accurate delivery during intravenous infusion. This form minimizes waste and supports optimal therapeutic outcomes by enabling medical professionals to administer the correct dose every time.
Trusted Quality from India's Pharmaceutical SectorSourced and manufactured in India, Krabeva meets stringent quality standards, reflecting the country's expertise in pharmaceutical production. The product's liquid formulation is suitable for clinical protocols, and its distribution network covers exporters, suppliers, traders, and wholesalers.
FAQ's of Krabeva 400 mg Injection:
Q: How should Krabeva 400 mg Injection be administered?
A: Krabeva 400 mg Injection must be administered via intravenous infusion by a qualified healthcare professional. The single-dose vial is intended for one-time use and should not be reused.
Q: What is the recommended usage of Krabeva 400 mg Injection?
A: This medication is recommended specifically for doctors and should be used under strict medical supervision, according to established protocols and patient-specific requirements.
Q: When is Krabeva 400 mg Injection typically prescribed?
A: Doctors prescribe Krabeva 400 mg Injection during treatment regimens that require intravenous therapies, as determined by individual patient assessments and clinical needs.
Q: Where is Krabeva 400 mg Injection manufactured and distributed?
A: Krabeva 400 mg Injection is manufactured in India and is available through a network of distributors, exporters, suppliers, traders, and wholesalers.
Q: What is the process for sourcing Krabeva 400 mg Injection for clinics?
A: Clinics and healthcare providers can procure Krabeva through authorized distributors, exporters, suppliers, traders, or wholesalers who deal in pharmaceutical products originating from India.
Q: What are the benefits of using Krabeva 400 mg Injection?
A: Krabeva 400 mg Injection delivers reliable dosing through its single-use vial design and is formulated for effective intravenous administration, supporting safety and therapeutic efficacy in medical treatments.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese